ArriVent BioPharma, Inc. AVBP Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $37.62M+16.9% | $32.18M0.0% | $32.17M+16.0% | $27.72M-54.8% | $61.29M+204% | ||
| $8.49M+27.8% | $6.65M+8.1% | $6.15M+4.2% | $5.9M+7.7% | $5.48M+54.8% | ||
| $46.11M+18.8% | $38.82M+1.3% | $38.32M+14.0% | $33.62M-49.6% | $66.77M+182% | ||
| -$46.11M-18.8% | -$38.82M-1.3% | -$38.32M-14.0% | -$33.62M+49.6% | -$66.77M-182% | ||
| -$43.32M-21.9% | -$35.54M-1.6% | -$34.98M-11.4% | -$31.4M+51.2% | -$64.39M-212% | ||
| -$0.96-23.1% | -$0.78+6.0% | -$0.83+7.8% | -$0.90+52.6% | -$1.90-211% | ||
| -$46.67M-17.9% | -$39.58M-1.3% | -$39.07M-13.7% | -$34.38M+49.1% | -$67.53M— | ||
| -$46.11M-18.8% | -$38.82M-1.3% | -$38.32M-14.0% | -$33.62M+49.6% | -$66.77M-182% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does ArriVent BioPharma, Inc.'s income statement data come from?
- Every line is extracted from ArriVent BioPharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.